Multi-center, randomized, double-blinded assessment of Tecfidera in extending the time to a first attack in radiologically isolated syndrom (RIS) (ARISE)
A study for patients with Multiple Sclerosis using study drug called Tecfidera
Sponsor: University of Texas Southwestern
Enrolling: Male and Female Patients
IRB Number: AAAQ9874
U.S. Govt. ID: NCT02739542
Contact: Wendy Vargas: 646-426-3876 /
Additional Study Information: This study is being done to find out whether drug that is used for relapsing forms of multiple sclerosis (MS) called Tecfidera (dimethyl fumarate) can delay the onset of MS symptoms in people with radiographically isolated syndrome. Half the participants enrolled in this study will receive the medication and half will receive a placebo (no active ingredient). Neither participants or the study team will choose or even know which treatment they are getting.
This study is closed
Wendy Vargas, MD
Do You Qualify?
Have you been diagnosed with Multiple Sclerosis? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Wendy Vargas